Lumen - Biologic Drug for Traveler’s Diarrhea

Supported in part by funding from the Bill & Melinda Gates Foundation, Lumen’s traveler’s diarrhea product is a cocktail of neutralizing monoclonal antibody-like protein biologics designed to bind and neutralize the primary causes of traveler’s diarrhea:  the bacterial pathogens Campylobacter jejuni and enterotoxigenic E. coli. In addition to making life miserable for travelers and deployed servicemen and -women, they are a major cause of infant mortality and morbidity in the developing world. Lumen is committed to working with the Gates Foundation and other global health advocates to make these products available in the developing world, regardless of ability to pay.